Clinical Trial Update: Effects of Pioglitazone in Congenital Adrenal Hyperplasia [NA]

View source ↗

Summary

This clinical trial update reports the completion of a study evaluating pioglitazone in patients with congenital adrenal hyperplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Adrenal Hyperplasia

Drugs mentioned

• Actos (pioglitazone) (pioglitazone)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Congenital Adrenal Hyperplasia | NA | Status: COMPLETED